Moreover, the analysis of DFS data revealed associations between high IRAK1 expression and poor prognosis among patients with ACC (p = 0.0097, HR (high) = 2.4), DLBC (p = 0.048, HR (high) = 3.6), KICH (p = 0.075, HR (high) = 3.2), LGG (p = 0.001, HR (high) = 1.7), MESO (p = 0.028, HR (high) = 1.9), PAAD (p = 0.015, HR (high) = 1.7), PRAD (p = 0.019, HR (high) = 1.6), and UVM (p = 0.042, HR (high) = 2.6) (Figure 3). This evidence concerns the gene IRAK1 and adrenal cortex carcinoma.